Viewing Study NCT07185269


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2026-01-17 @ 6:09 AM
Study NCT ID: NCT07185269
Status: RECRUITING
Last Update Posted: 2025-11-26
First Post: 2025-09-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Purpose of This Study is to Evaluate the Efficacy and Safety of 626 in the Treatment of SLE
Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Systemic Lupus Erythematosus (SLE) View
Keywords: